References
- WatsonPPostherpetic neuralgiaAm Fam Physician201184669069221916395
- TontodonatiMUrsiniTPolilliEPost-herpetic neuralgiaInt J Gen Med2012586187123109810
- HarpazRNagelMASchmaderKTyringSKYawnBPRoundtable on postherpetic neuralgia – what, why, how long, and what’s next?Popul Health Manag201215638539023088665
- FrischSGuoAMDiagnostic methods and management strategies of herpes simplex and herpes zoster infectionsClin Geriatr Med201329250152623571042
- Centers for Disease Control and PreventionShingles (herpes zoster)2011 Available from: http://www.cdc.gov/shingles/aboutAccessed January 15, 2014
- RedaHGreeneKRiceFLRowbothamMCPetersenKLNatural history of herpes zoster: late follow-up of 3.9 years (n=43) and 7.7 years (n=10)Pain2013154102227223323719573
- BaronRMechanisms of postherpetic neuralgia – we are hot on the scentPain2008140339539619004555
- PickeringGLeplegeAHerpes zoster pain, postherpetic neuralgia, and quality of life in the elderlyPain Pract201111439740221199312
- DroletMBrissonMLevinMJA prospective study of the herpes zoster severity of illnessClin J Pain201026865666620842005
- WeaverBAHerpes zoster overview: natural history and incidenceJ Am Osteopath Assoc2009109Suppl 2S2S619553632
- JungBFJohnsonRWGriffinDRDworkinRHRisk factors for postherpetic neuralgia in patients with herpes zosterNeurology20046291545155115136679
- OpsteltenWZuithoffNPvan EssenGAPredicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic studyPain2007132Suppl 1S52S5917379412
- ChristensenKDoblhammerGRauRVaupelJWAgeing populations: the challenges aheadLancet200937496961196120819801098
- US Census BureauNational population projection summary tables2012 Available from: http://www.census.gov/prod/2011pubs/12statab/pop.pdfAccessed January 15, 2014
- BennettGJWatsonCPHerpes zoster and postherpetic neuralgia: past, present and futurePain Res Manag200914427528219714266
- JohnsonRWHerpes zoster and postherpetic neuralgia: a review of the effects of vaccinationAging Clin Exp Res200921323624319571648
- GanEYTianEATeyHLManagement of herpes zoster and post-herpetic neuralgiaAm J Clin Dermatol2013142778523456596
- HardenRNKayeADKintanarTArgoffCEEvidence-based guidance for the management of postherpetic neuralgia in primary carePostgrad Med2013125419120223933906
- GoldmanGSKingPGReview of the United States universal varicella vaccination program: herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project dataVaccine201331131680169422659447
- DroletMOxmanMNLevinMJVaccination against herpes zoster in developed countries: state of the evidenceHum Vaccin Immunother2013951177118423324598
- BilckeJOgunjimiBHulstaertFVan DammePHensNBeutelsPEstimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?Vaccine201230172795280021964056
- FashnerJBellALHerpes zoster and postherpetic neuralgia: prevention and managementAm Fam Physician201183121432143721671543
- ThakurRPhilipAGChronic pain perspectives: treating herpes zoster and postherpetic neuralgia: an evidence-based approachJ Fam Pract201261Suppl 9S9S1523000670
- SaksGMUnmet need in the treatment of postherpetic neuralgiaAm J Manag Care201319Suppl 1S207S21323448093
- KlompasMKulldorffMVilkYBialekSRHarpazRHerpes zoster and postherpetic neuralgia surveillance using structured electronic dataMayo Clin Proc201186121146115321997577
- DubinskyRMKabbaniHEl-ChamiZBoutwellCAliHPractice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology200463695996515452284
- DworkinRHO’ConnorABAudetteJRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateMayo Clin Proc201085Suppl 3S3S1420194146
- AttalNCruccuGBaronREFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol20101791113e8820402746
- RastogiRMeekBDManagement of chronic pain in elderly, frail patients: finding a suitable, personalized method of controlClin Interv Aging20138374623355774
- AbdullaAAdamsNBoneMGuidance on the management of pain in older peopleAge Ageing201342Suppl 1i1i5723420266
- GlauserTASalinasGDNevinsHWilliamsonJCWallaceMSAbdolrasulniaMCommunication gaps between physicians and patients with postherpetic neuralgia: results from a national study on practice patternsJ Pain Res2011440741522247624
- DworkinRHPanaritesCJArmstrongEPMaloneDCPhamSVIs treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations?Pain2012153486987522356792
- DworkinRHSchmaderKETreatment and prevention of postherpetic neuralgiaClin Infect Dis200336787788212652389
- PickeringGPereiraBClereFCognitive function in older patients with postherpetic neuralgiaPain Pract Epub5232013
- American Geriatrics Society Beers Criteria Update Expert PanelAmerican Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adultsJ Am Geriatr Soc201260461663122376048
- LabiancaRSarzi-PuttiniPZuccaroSMCherubinoPVellucciRFornasariDAdverse effects associated with non-opioid and opioid treatment in patients with chronic painClin Drug Investig201232Suppl 15363
- ChouRFanciulloGJFinePGClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
- MerckVarivax [prescribing information]2013 Available from: http://www.merck.com/product/usa/pi_circulars/v/varivax/varivax_pi.pdfAccessed January 15, 2014
- MerckZostavax [prescribing information]2006 Available from: http://www.merck.com/product/usa/pi_circulars/z/zostavax/zostavax_pi2.pdfAccessed January 15, 2014
- OxmanMNLevinMJJohnsonGRA vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsN Engl J Med2005352222271228415930418
- GagliardiAMGomes SilvaBNTorloniMRSoaresBGVaccines for preventing herpes zoster in older adultsCochrane Database Syst Rev201210CD00885823076951
- SchmaderKEOxmanMNLevinMJPersistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudyClin Infect Dis201255101320132822828595
- CohenEJPrevention of herpes zoster: we need to do betterJAMA Ophthalmol2013131339639823494045
- JavedSJavedFMaysRMTyringSKHerpes zoster vaccine awareness among people ≥50 years of age and its implications on immunizationDermatol Online J2012188222948052
- BruxelleJPinchinatSEffectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: review of international publicationsMed Mal Infect2012422535822169279
- GlaxoSmithKline AustraliaZovirax [prescribing information]2013 Available from: http://www.gsk.com.au/products_prescription-medicines_detail.aspx?view=153Accessed February 6, 2014
- NovartisFamvir [prescribing information]2013 Available from: http://www.pharma.us.novartis.com/product/pi/pdf/Famvir.pdfAccessed February 3, 2014
- GlaxoSmithKlineValtrex [prescribing information]2013 Available from: http://us.gsk.com/products/assets/us_valtrex.pdfAccessed January 15, 2014
- WoodMJShuklaSFiddianAPCrooksRJTreatment of acute herpes zoster: effect of early (<48 h) versus late (48–72 h) therapy with acyclovir and valaciclovir on prolonged painJ Infect Dis1998178Suppl 1S81S849852981
- LapollaWDigiorgioCHaitzKIncidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label studyArch Dermatol2011147890190721482862
- HanYZhangJChenNHeLZhouMZhuCCorticosteroids for preventing postherpetic neuralgiaCochrane Database Syst Rev20133CD00558223543541
- PfizerNeurontin [prescribing information]2012 Available from: http://labeling.pfizer.com/ShowLabeling.aspx?id=630Accessed January 15, 2014
- BackonjaMGlanzmanRLGabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trialsClin Ther20032518110412637113
- JohnsonPBeckerLHalpernRSweeneyMReal-world treatment of post-herpetic neuralgia with gabapentin or pregabalinClin Drug Investig20133313544
- DepomedGralise [prescribing information]2012 Available from: http://www.gralise.com/lib/PDFS/GRALISE_PI.pdfAccessed January 15, 2014
- XenoPortHorizant [prescribing information] Available from: http://www.horizant.com/docs/Horizant_PrescribingInformation.pdfAccessed January 15, 2014
- IrvingGASweeneyMTolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgiaJ Pain Res2012520320822792006
- ZhangLRainkaMFreemanRA randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748)J Pain201314659060323602345
- PfizerLyrica [prescribing information]2013 Available from: http://labeling.pfizer.com/ShowLabeling.aspx?id=561Accessed January 15, 2014
- EndoLidoderm [prescribing information] Available from: http://www.endo.com/File%20Library/Products/Prescribing%20Information/LIDODERM_prescribing_information.htmlAccessed January 15, 2014
- Acorda TherapeuticsQutenza [prescribing information] Available from: http://www.qutenza.com/_docs/qutenza_full_PI_.pdfAccessed January 15, 2014
- SaartoTWiffenPJAntidepressants for neuropathic pain: a Cochrane reviewJ Neurol Neurosurg Psychiatry201081121372137320543189
- WatsonCPVernichLChipmanMReedKNortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trialNeurology1998514116611719781549
- WatsonCPTylerKLBickersDRMillikanLESmithSColemanEA randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgiaClin Ther19931535105268364943
- StempniakMClosing the primary care gapHosp Health Netw2013873455223617120
- WolffKJohnsonRFitzpatrickTBFitpatrick’s color atlas and synopsis of clinical dermatology5th EdNew YorkMcGraw-Hill Education2005